BridgeMD
New treatment option for Newborn; Vitality
Official title Effect of Intranasal Breast Milk Administration in Preterm Infants
ClinicalTrials.gov ID: NCT06706115
What this study is testing
- What it's testing
- The aim of the study was to investigate the effect of intranasal breast milk administration on cerebral oxygenation level, vital signs and time to full oral feeding in preterm infants.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 28 to 37. Healthy volunteers may be eligible.
You may be able to join if
- Birth weight \>1000 gr,
- APGAR score \>7 at 5 minutes after birth,
- Availability of breast milk,
- No medical diagnosis affecting cerebral oxygenation (intraventricular hemorrhage, cardiovascular and neurological disorders, anemia),
- No congenital anomalies or chromosomal abnormalities,
You likely can't join if
- Being able to feed orally in all feedings
- Being fed entirely on formula milk,
- Administration of medication via the nasal route,
- Being intubated or receiving continuous positive air pressure (CPAP) support,
- Maternal substance abuse, alcohol abuse, HIV infection, untreated active tuberculosis, chemotherapy or radiotherapy treatment,
- The mother has mastitis, breast trauma, abscesses or is taking any medication that passes into the milk,
See the full eligibility criteria
- Birth weight \>1000 gr,
- APGAR score \>7 at 5 minutes after birth,
- Availability of breast milk,
- No medical diagnosis affecting cerebral oxygenation (intraventricular hemorrhage, cardiovascular and neurological disorders, anemia),
- No congenital anomalies or chromosomal abnormalities,
- No congenital anomaly (such as cleft palate) affecting nasal patency.
- Being able to feed orally in all feedings
- Being fed entirely on formula milk,
- Administration of medication via the nasal route,
- Being intubated or receiving continuous positive air pressure (CPAP) support,
- Maternal substance abuse, alcohol abuse, HIV infection, untreated active tuberculosis, chemotherapy or radiotherapy treatment,
- The mother has mastitis, breast trauma, abscesses or is taking any medication that passes into the milk,
- The mother does not want to express milk.
The study team makes the final eligibility decision.
Where it's taking place
- Konya, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 28 weeks to 37 weeks. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Konya, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.